Wendie N. Marks

Wendie N. Marks

Auto-generated profile, based on publicly available information

Wendie N. Marks

Department of Pediatrics, University, Saskatoon, SK, Canada

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 June 2022 in JCI Insight
Verified
Journal Article
Open access
PDF file
CMChunlong Mu
Chunlong Mu
NNNaghmeh Nikpoor
Naghmeh Nikpoor
Thomas A. TompkinsThomas A. Tompkins
Thomas A. Tompkins
ACAnamika Choudhary
Anamika Choudhary
MWMelinda Wang
Melinda Wang
Jane ShearerJane Shearer
Jane Shearer
Infantile spasms syndrome (IS) is a devastating early-onset epileptic encephalopathy associated with poor neurodevelopmental outcomes. When first-line treatment options, including adrenocorticotropic hormone and vigabatrin, are ineffective, the ketogenic diet (KD) is often employed to control seizures. Since the therapeutic impact of the KD is influenced by the gut microbiota, we examined whether targeted microbiota manipulation, mimicking changes induced by the KD, would be valuable in mitigating seizures. Employing a rodent model of symptomatic IS, we show that both the KD and antibiotic administration reduce spasm frequency and are associated with improved developmental outcomes. Spasm reductions were accompanied by specific gut microbial alterations, including increases in Streptococcus thermophilus and Lactococcus lactis . Mimicking the fecal microbial alterations in a targeted probiotic, we administered these species in a 5:1 ratio. Targeted probiotic administration reduced seizures and improved locomotor activities in control diet–fed animals, similar to KD-fed animals, while a negative control ( Ligilactobacillus salivarius ) had no impact. Probiotic administration also increased antioxidant status and decreased proinflammatory cytokines. Results suggest that a targeted probiotic reduces seizure frequency, improves locomotor activity in a rodent model of IS, and provides insights into microbiota manipulation as a potential therapeutic avenue for pediatric epileptic encephalopathies.

1 June 2021 in Neuropharmacology
Verified
Journal Article
Closed access
ARAndrew J. Roebuck
Andrew J. Roebuck
QGQuentin Greba
Quentin Greba
ASAnna-Maria Smolyakova
Anna-Maria Smolyakova
MAMariam Alaverdashvili
Mariam Alaverdashvili
WMWendie N. Marks
Wendie N. Marks
RLRobert B. Laprairie
Robert B. Laprairie

1 April 2019 in Behavioural Brain Research
Verified
Journal Article
Closed access
WMWendie N. Marks
Wendie N. Marks
NZNadine K. Zabder
Nadine K. Zabder
SCStuart M. Cain
Stuart M. Cain
TSTerrance P. Snutch
Terrance P. Snutch
JHJohn G. Howland
John G. Howland

19 March 2019 in European Journal of Neuroscience
Verified
Journal Article
Closed access
PDF file
WMWendie N. Marks
Wendie N. Marks
NZNadine K. Zabder
Nadine K. Zabder
QGQuentin Greba
Quentin Greba
SCStuart M. Cain
Stuart M. Cain
TSTerrance P. Snutch
Terrance P. Snutch
JHJohn G. Howland
John G. Howland

31 May 2022 in JMIR Public Health and Surveillance
Verified
Journal Article
Open access
DADaniel A Adeyinka
Daniel A Adeyinka
CNCory Neudorf
Cory Neudorf
CCCheryl A. Camillo
Cheryl A. Camillo
WMWendie N Marks
Wendie N Marks
NMNazeem Muhajarine
Nazeem Muhajarine
Background: There is mounting evidence that the third wave of COVID-19 incidence is declining, yet variants of concern (VOCs) continue to present public health challenges in Canada. The emergence of VOCs has sparked debate on how to effectively control their impacts on the Canadian population. Objective: Provincial and territorial governments have implemented a wide range of policy measures to protect residents against community transmission of COVID-19, but research examining the specific impact of policy countermeasures on the VOCs in Canada is needed. Our study objective was to identify provinces with disproportionate prevalence of VOCs relative to COVID-19 mitigation efforts in provinces and territories in Canada. Methods: We analyzed publicly available provincial- and territorial-level data on the prevalence of VOCs in relation to mitigating factors, summarized in 3 measures: (1) strength of public health countermeasures (stringency index), (2) the extent to which people moved about outside their homes (mobility index), and (3) the proportion of the provincial or territorial population that was fully vaccinated (vaccine uptake). Using spatial agglomerative hierarchical cluster analysis (unsupervised machine learning), provinces and territories were grouped into clusters by stringency index, mobility index, and full vaccine uptake. The Kruskal-Wallis test was used to compare the prevalence of VOCs (Alpha, or B.1.1.7; Beta, or B.1.351; Gamma, or P.1; and Delta, or B.1.617.2 variants) across the clusters. Results: We identified 3 clusters of vaccine uptake and countermeasures. Cluster 1 consisted of the 3 Canadian territories and was characterized by a higher degree of vaccine deployment and fewer countermeasures. Cluster 2 (located in Central Canada and the Atlantic region) was typified by lower levels of vaccine deployment and moderate countermeasures. The third cluster, which consisted of provinces in the Pacific region, Central Canada, and the Prairies, exhibited moderate vaccine deployment but stronger countermeasures. The overall and variant-specific prevalences were significantly different across the clusters. Conclusions: This “up to the point” analysis found that implementation of COVID-19 public health measures, including the mass vaccination of populations, is key to controlling VOC prevalence rates in Canada. As of June 15, 2021, the third wave of COVID-19 in Canada is declining, and those provinces and territories that had implemented more comprehensive public health measures showed lower VOC prevalence. Public health authorities and governments need to continue to communicate the importance of sociobehavioural preventive measures, even as populations in Canada continue to receive their primary and booster doses of vaccines.

6 February 2024 in International Journal of Circumpolar Health
Verified
Journal Article
Open access
RDRosalie Dostie
Rosalie Dostie
HDHailey Dunn
Hailey Dunn
WMWendie N. Marks
Wendie N. Marks
CCChantal Camden
Chantal Camden
SLStacey Lovo
Stacey Lovo
Telerehabilitation is proposed as a promising avenue to enhance service accessibility for Indigenous communities, yet its application for Indigenous children remains relatively unexplored. This scoping review followed the PRISMA-ScR framework to explore current knowledge on the use of telerehabilitation for Indigenous children. Ten scholarly databases, seven grey literature databases, reference searches, and expert consultations were utilised to identify relevant studies. Included articles discussed the use of telerehabilitation provided by rehabilitation professionals (e.g. occupational therapist (OT), physical therapist (PT), speech and language pathologist (SLP) to Indigenous children and/or caregivers. Seven studies were included. Telerehabilitation was explored in different ways, the most common being real-time videoconferencing by SLPs. While some studies explicitly acknowledged cultural responsiveness within both the research process and the intervention, most were not designed for Indigenous children and their caregivers; rather, these participants were included with non-Indigenous participants. Successful implementation and sustainability of telerehabilitation services requires addressing technological limitations, understanding, and respecting diverse worldviews, and co-developing services to meet the unique needs of Indigenous families. Telerehabilitation has been rarely used with Indigenous children and when it was, little attention was given to cultural considerations. These findings emphasise that future telerehabilitation interventions should be truly community-led to ensure cultural relevance.